Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GLENMARK PHARMA vs BIOCON - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    GLENMARK PHARMA BIOCON GLENMARK PHARMA/
BIOCON
 
P/E (TTM) x -31.4 19.7 - View Chart
P/BV x 2.9 1.8 158.5% View Chart
Dividend Yield % 0.3 0.6 46.0%  

Financials

 GLENMARK PHARMA   BIOCON
EQUITY SHARE DATA
    GLENMARK PHARMA
Mar-23
BIOCON
Mar-23
GLENMARK PHARMA/
BIOCON
5-Yr Chart
Click to enlarge
High Rs487388 125.6%   
Low Rs349192 182.1%   
Sales per share (Unadj.) Rs460.493.1 494.6%  
Earnings per share (Unadj.) Rs13.45.4 249.7%  
Cash flow per share (Unadj.) Rs35.014.6 239.5%  
Dividends per share (Unadj.) Rs2.501.50 166.7%  
Avg Dividend yield %0.60.5 115.5%  
Book value per share (Unadj.) Rs335.1146.5 228.7%  
Shares outstanding (eoy) m282.171,200.60 23.5%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x0.93.1 29.2%   
Avg P/E ratio x31.354.1 57.8%  
P/CF ratio (eoy) x11.919.8 60.2%  
Price / Book Value ratio x1.22.0 63.1%  
Dividend payout %18.728.0 66.7%   
Avg Mkt Cap Rs m117,953347,814 33.9%   
No. of employees `000NANA-   
Total wages/salary Rs m27,81021,810 127.5%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m129,901111,742 116.3%  
Other income Rs m3,1687,681 41.2%   
Total revenues Rs m133,069119,423 111.4%   
Gross profit Rs m15,12516,611 91.1%  
Depreciation Rs m6,11311,131 54.9%   
Interest Rs m3,4964,190 83.4%   
Profit before tax Rs m8,6858,971 96.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m4,9112,541 193.3%   
Profit after tax Rs m3,7746,430 58.7%  
Gross profit margin %11.614.9 78.3%  
Effective tax rate %56.528.3 199.6%   
Net profit margin %2.95.8 50.5%  
BALANCE SHEET DATA
Current assets Rs m98,737123,340 80.1%   
Current liabilities Rs m50,45585,107 59.3%   
Net working cap to sales %37.234.2 108.6%  
Current ratio x2.01.4 135.0%  
Inventory Days Days7129 5.2%  
Debtors Days Days115117 98.7%  
Net fixed assets Rs m76,920394,078 19.5%   
Share capital Rs m2826,003 4.7%   
"Free" reserves Rs m94,281169,926 55.5%   
Net worth Rs m94,563175,929 53.8%   
Long term debt Rs m38,521152,905 25.2%   
Total assets Rs m175,658517,418 33.9%  
Interest coverage x3.53.1 110.9%   
Debt to equity ratio x0.40.9 46.9%  
Sales to assets ratio x0.70.2 342.4%   
Return on assets %4.12.1 201.6%  
Return on equity %4.03.7 109.2%  
Return on capital %9.24.0 228.7%  
Exports to sales %03.1 0.0%   
Imports to sales %06.0 0.0%   
Exports (fob) Rs mNA3,467 0.0%   
Imports (cif) Rs mNA6,654 0.0%   
Fx inflow Rs m46,4643,467 1,340.2%   
Fx outflow Rs m12,7126,654 191.0%   
Net fx Rs m33,751-3,187 -1,059.0%   
CASH FLOW
From Operations Rs m6,25418,525 33.8%  
From Investments Rs m-5,285-142,818 3.7%  
From Financial Activity Rs m-775130,487 -0.6%  
Net Cashflow Rs m3256,411 5.1%  

Share Holding

Indian Promoters % 46.7 40.4 115.6%  
Foreign collaborators % 0.0 20.3 -  
Indian inst/Mut Fund % 34.7 21.1 164.6%  
FIIs % 23.7 6.6 362.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 53.4 39.4 135.5%  
Shareholders   209,931 434,339 48.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare GLENMARK PHARMA With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Glenmark Pharma vs Biocon

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Glenmark Pharma vs Biocon Share Price Performance

Period Glenmark Pharma Biocon S&P BSE HEALTHCARE
1-Day -0.57% 2.92% 1.18%
1-Month 5.16% -2.53% -0.75%
1-Year 112.94% 30.52% 61.82%
3-Year CAGR 27.51% -13.55% 18.16%
5-Year CAGR 8.05% -2.73% 19.79%

* Compound Annual Growth Rate

Here are more details on the Glenmark Pharma share price and the Biocon share price.

Moving on to shareholding structures...

The promoters of Glenmark Pharma hold a 46.7% stake in the company. In case of Biocon the stake stands at 60.6%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Glenmark Pharma and the shareholding pattern of Biocon.

Finally, a word on dividends...

In the most recent financial year, Glenmark Pharma paid a dividend of Rs 2.5 per share. This amounted to a Dividend Payout ratio of 18.7%.

Biocon paid Rs 1.5, and its dividend payout ratio stood at 28.0%.

You may visit here to review the dividend history of Glenmark Pharma, and the dividend history of Biocon.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.